AstraZeneca PLC

AZN-GB:London Stock Exchange
RT Quote | Exchange | GBp
Last | 01/20/21 GMT
7,645.00UNCH (UNCH)
52 week range
5,871.00 - 10,120.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7,645.00
  • 52 Week High10,120.00
  • 52 Week High Date07/20/20
  • 52 Week Low5,871.00
  • 52 Week Low Date03/16/20
  • Market Cap135,549.97M
  • Shares Out1,312.3M
  • 10 Day Average Volume2.25M
  • Dividend216.00
  • Dividend Yield2.83%
  • Beta0.22
  • 1 Year % Change-1.48

RATIOS/PROFITABILITY

  • EPS (TTM)146.98
  • P/E (TTM)52.01
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/13/2020
  • Div Amount69.60
  • Split Date-
  • Split Factor-

Latest AZN-GB News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Related Video

VIDEO2:1902:19
15 million vaccine doses distributed, but only 4.5 million given: CDC

Profile

MORE
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of...
Leif Johansson
Non-Executive Chairman
Pascal Soriot
Chief Executive Officer
Marc Dunoyer
Chief Financial Officer
Ruud Dobber
Executive Vice President
Menelas Pangalos
Executive Vice President
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom